default author photo

Heinz-Josef Lenz

University of Southern California - Norris Comprehensive Cancer Center

1441 Eastlake Ave

Los Angeles, CA 90089

United States

SCHOLARLY PAPERS

2

DOWNLOADS

232

TOTAL CITATIONS

3

Scholarly Papers (2)

1.

Regorafenib Dose-Optimization Study (ReDOS): A Phase 2 Randomized Study to Evaluate Dosing Strategies for Regorafenib in Patients with Refractory Metastatic Colorectal Cancer - An ACCRU Network Study

Number of pages: 28 Posted: 28 Jan 2019
Mayo Clinic Hospital - Phoenix - Division of Medical Oncology, Mayo Clinic, Mayo Clinic Hospital - Phoenix - Division of Medical Oncology, Roswell Park Comprehensive Cancer Center, Vanderbilt University - Department of Medicine, Mayo Clinic, Mayo Clinic, Minnesota Oncology, Wake Forest University - Comprehensive Cancer CenterWake Forest University - Department of Cancer Biology, Harvard University - Dana-Farber Cancer Institute, Mayo Clinic, University of Washington, Washington University in St. Louis - Department of Medicine, University of Southern California - Norris Comprehensive Cancer Center, University of Washington - School of Medicine, Mayo Clinic, Memorial Sloan Kettering Cancer Center - Department of Medicine, University of Southern California - Norris Comprehensive Cancer Center and West Cancer Center and Research Institute
Downloads 138 (530,816)
Citation 3

Abstract:

Loading...

Refractory metastatic colorectal cancer, Regorafenib, Dose-optimization, Phase 2, Dosing strategies

2.

BMAL1 Links Bevacizumab Resistance in Colorectal Cancer to Circadian Rhythm and Heme Receptor REVERBA

Number of pages: 54 Posted: 07 Apr 2019
Heidelberg University - Department of Medicine II, University of Southern California - Norris Comprehensive Cancer Center, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, RWTH Aachen University - Faculty of Medicine, Heidelberg University - Faculty of Medicine, Heidelberg University - Faculty of Medicine, Heidelberg University - Faculty of Medicine, Heidelberg University - Department of Medical Statistics and Biomathematics, Heidelberg University - Faculty of Medicine, Royal College of Surgeons in Ireland (RCSI), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - IRCCS Veneto Institute of Oncology (IOV-IRCCS), University of Southern California - Norris Comprehensive Cancer Center, Royal College of Surgeons in Ireland (RCSI) and Heidelberg University - Department of Medicine II
Downloads 94 (720,278)

Abstract:

Loading...

BMAL1; REVERBA; circadian rhythm; bevacizumab; colorectal cancer